DSpace Repository
Durable complete response after discontinuation of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma with portal vein tumor thrombosis: the first report
- DSpace Home
- →
- Gastroenterology
- →
- Journal Publications
- →
- View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.
